A Study of the inhibitory effect of Terpinen-4-ol on Amastigote Forms of Leishmania tropica within Macrophages of Mouse in vitro

Authors

  • Abdulazim Mohammed Hami Faculty of pharmacy, Damascus University

DOI:

https://doi.org/10.31351/vol31iss2pp233-236

Keywords:

Terpinen-4-ol, amastigote forms, promastigote forms, macrophages, viability.

Abstract

It was recorded that Terpinen-4-ol has an anti-parasitic properties, so it will be noteworthy to intensify the studies about this compound.

This study aims to test the effectiveness of terpinen-4-ol on amastigote forms of Leishmania parasite in macrophages.

This effect was studied by adding increasing concentrations  of  Terpinen-4-ol to  culture wells containing mouse macrophages that were previously incubated with the promastigote forms of the parasites for 24 hours .Then, they were incubated for another 24 hours with increasing concentrations of Terpinen-4-ol.  After, Parasites were enumerated into macrophages in wells either treated with Terpinen-4-ol or in control wells.

Treatment with Terpinen-4-ol at concentrations (0.01%, 0.02%, 0.05%, 0.1%) (v/v) decreased the viability of the amastigote forms inside macrophages (24.02%, 32.74%, 66.72%, 100%) respectively, compared to control wells (water only). 

This study demonstrated an activity of Terpinen-4-ol against amastigote forms of Leishmania tropica in vitro with minimal inhibitory concentration (MIC50) value was 0.0416% (v/v).

How to Cite

1.
Hami AM. A Study of the inhibitory effect of Terpinen-4-ol on Amastigote Forms of Leishmania tropica within Macrophages of Mouse in vitro. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2022 Dec. 24 [cited 2024 Dec. 22];31(2):233-6. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1553

Publication Dates

References

Torres-Guerrero, E., et al., Leishmaniasis: a review. 2017. 6.

Meireles, C.B., et al., Atypical presentations of cutaneous leishmaniasis: a systematic review. 2017; 172: 240-254.

Ergen, E.N., A.H. King, and M.J.C. Tuli, Cutaneous leishmaniasis: an emerging infectious disease in travelers. 2015. 96(4): E22-E26.

Norouzinezhad, F., et al., Cutaneous leishmaniasis in Iran: results from an epidemiological study in urban and rural provinces. 2016;6(7): 614-619.

Salam, N., W.M. Al-Shaqha, and A.J.P.n.t.d. Azzi, Leishmaniasis in the Middle East: incidence and epidemiology. 2014; 8(10): e3208.

Abdrebbi, S.B., et al., Cutaneous Leishmaniasis: endemic regions and epidemiological characteristics of cases declared at University Hospital Center of Tlemcen, Algeria. 2019; 7: 249-254.

Haddad, N., et al., Cutaneous leishmaniasis in the central provinces of Hama and Edlib in Syria: Vector identification and parasite typing. 2015; 8(1): 1-8.

Hayani, K., A. Dandashli, and E.J.A.d.-v. Weisshaar, Cutaneous leishmaniasis in Syria: clinical features, current status and the effects of war. 2015; 95(1): 62-66.

Dantas-Torres, F., et al., Detection of Leishmania infantum in Rhipicephalus sanguineus ticks from Brazil and Italy. 2010; 106(4): 857-860.

Barrera, C.A.C., et al., Seco-limonoids and quinoline alkaloids from Raputia heptaphylla and their antileishmanial activity. 2011;59(7): 855-859.

Fever, D., Kala-azar, Black Fever, Dumdum Fever, Oriental Sore, Tropical Sore, Uta, Chiclero Ulcer, Aleppo Boi, Pian Bois; Espundia. 2009.

Habif, T.P.J.A., Netherlands: Elsevier Health Sciences, Clinical dermatology e-book: a color guide to diagnosis and therapy. 2015.

Mertas, A., et al., The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains. 2015.

Pazyar, N., et al., A review of applications of tea tree oil in dermatology. 2013;52(7): 784-790.

Mondello, F., et al., In vitro and in vivo activity of tea tree oil against azole-susceptible and-resistant human pathogenic yeasts. 2003;51(5): 1223-1229.

Naddaf, N. and S.J.J.o.P.D. Haddad, Apigenin effect against Leishmania tropica amastigotes in vitro. 2020;44: 574-578.

Downloads

Published

2022-12-24